IP Library Granted Patent US 7,208,282
Granted Patent B2
US 7,208,282 · App. 10/478,534 · Granted Apr 24, 2007

Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,282
App. No.
10/478,534
Granted
Apr 24, 2007
Kind
B2
Abstract

The present invention identifies the presence of MCH-2R in the dog, ferret and rhesus monkey. MCH-2R is a G-protein coupled receptor that responds to MCH and is distinct from MCH-1R. MCH-2R polypeptide and nucleic acid sequences related to the dog, ferret, and rhesus monkey MCH-2R are described herein along with uses of such polypeptides and nucleic acids.

Claims (20)

1. A purified polypeptide comprising an amino acid SEQ ID NO: 9.

2. The polypeptide of claim 1 , wherein said polypeptide consists of an MCH-2R dog, ferret, or rhesus sequence comprising SEQ ID NO: 9.

3. The polypeptide of claim 1 , wherein said polypeptide comprises a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3.

4. The polypeptide of claim 3 , wherein said polypeptide consists of SEQ ID NO: 1.

5. The polypeptide of claim 3 , wherein said polypeptide consists of SEQ ID NO: 2.

6. The polypeptide of claim 3 , wherein said polypeptide consists of SEQ ID NO: 3.

7. A purified nucleic acid comprising a nucleotide sequence selected from the group consisting of: SEQ ID NO: 13 and the complement of SEQ ID NO: 13.

8. A method of measuring the ability of a compound to affect MCH-2R activity comprising the steps of:

a) contacting a recombinant cell with said compound, wherein said recombinant cell comprises a recombinant nucleic acid expressing a functional MCH-2R that comprises the amino acid sequence of either SEQ ID NO: 1 SEQ ID NO: 2 or SEQ ID NO: 3; and

b) measuring MCH-2R activity.

9. The method of claim 8 , wherein said method further comprises the use of an MCH-2R agonist.

10. The method of claim 8 , wherein said amino acid sequence is SEQ ID NO: 3.

11. A recombinant nucleic acid comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 9.

12. The recombinant nucleic acid of claim 11 , wherein said nucleotide encodes the sequence of either SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3.

13. The recombinant nucleic acid of claim 12 , wherein said recombinant nucleic acid is an expression vector.

14. The recombinant nucleic acid of claim 11 , wherein said nucleotide sequence encodes SEQ ID NO: 3.

15. The recombinant nucleic acid of claim 11 , wherein said nucleotide sequence is selected from the group consisting of: SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7.

16. The recombinant nucleic acid of claim 15 , wherein said nucleotide sequence is NO: 7.

17. A recombinant cell comprising the expression vector of claim 12 , wherein said nucleotide sequence is functionally coupled to a promoter recognized by said cell.

18. A method of preparing a MCH-2R polypeptide comprising the step of growing the recombinant cell of claim 17 under conditions wherein said polypeptide is expressed from said expression vector.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2011
From: BANYU PHARMACEUTICAL CO., LTD.
To: MSD K.K.
Reel/Frame 025920/0079 →
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0910 →